JNJ has been in the news 333% more than usual
Sep 19, 2025, 6:31 PM
9.27%
What does JNJ do
Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
JNJ has been in the news recently: Johnson & Johnson and Protagonist Therapeutics presented new Phase 3 study data highlighting icotrokinra's effectiveness for moderate-to-severe plaque psoriasis compared to deucravacitinib. Additionally, Johnson & Johnson's therapies TECVAYLI® and DARZALEX FASPRO® demonstrated 100% minimal residual disease negativity in a study involving 46 patients.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.